Evolus (EOLS) Free Cash Flow (2017 - 2026)
Evolus (EOLS) reported Free Cash Flow of -$10.4 million for Q1 2026, up 35.01% on a YoY basis from -$7.7 million in Q1 2025, and down 191.36% quarter-over-quarter from $11.3 million in Q4 2025.
Evolus (EOLS) Free Cash Flow (2017 - 2026) Analysis & Trends
Evolus has reported Free Cash Flow for 10 years, with the latest figure at -$10.4 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 35.01% year-over-year to -$10.4 million; the trailing twelve-month figure through Mar 2026 stood at -$40.1 million (down 71.97% YoY), and the FY2025 full-year result was -$45.7 million, down 150.43% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$10.4 million, down from $11.3 million in the prior quarter.
- The five-year high for Free Cash Flow was $11.3 million in Q4 2025, with the low at -$38.2 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$11.5 million across 5 years, with a median of -$10.9 million in 2024.
- The largest YoY upside for Free Cash Flow was 825.5% in 2024 against a maximum downside of 767.1% in 2024.
- Evolus' Free Cash Flow stood at -$9.3 million in 2022, then surged by 106.46% to $604000.0 in 2023, then surged by 825.5% to $5.6 million in 2024, then surged by 103.01% to $11.3 million in 2025, then tumbled by 191.36% to -$10.4 million in 2026.
- The last three Free Cash Flow figures came in at -$10.4 million (Q1 2026), $11.3 million (Q4 2025), and -$15.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | -10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.37 Mn |
| Mar 31, 2026 | -10.37 Mn |
| Dec 31, 2025 | 11.35 Mn |
| Dec 31, 2025 | 11.35 Mn |
| Sep 30, 2025 | -15.62 Mn |
| Sep 30, 2025 | -15.62 Mn |
| Jun 30, 2025 | -25.48 Mn |
| Jun 30, 2025 | -25.48 Mn |
| Mar 31, 2025 | -15.95 Mn |
| Mar 31, 2025 | -15.95 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Sep 30, 2024 | -6.04 Mn |
| Sep 30, 2024 | -6.04 Mn |
| Jun 30, 2024 | -6.94 Mn |
| Jun 30, 2024 | -6.94 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Mar 31, 2024 | -10.87 Mn |
| Dec 31, 2023 | 604,000.00 |
| Dec 31, 2023 | 604,000.00 |